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Abstract: Bacterial lipopolysaccharide (LPS) also known as endotoxin, which represents the outer cell wall mem-
brane of gram-negative bacteria has been implicated as the major bacterial bone-resorbing factor. Recently, the 
most prevalent form of clinically significant osteopenia and osteoporosis involves periodontitis and otitis media by 
gram-negative bacteria. The aim of the study is to evaluate circulating endotoxin levels and to study the associa-
tion amongst endotoxin and bone turnover markers in a cohort of Saudi postmenopausal women with or without 
osteoporosis. We determined the levels of endotoxin, bone turnover markers, 25-OH vitamin D total and corrected 
calcium in 100 Saudi postmenopausal women with osteoporosis and 100 women without osteoporosis were taken 
under the supervision of qualified physicians in the primary care centers in Riyadh. Serum endotoxin, NTx, osteocal-
cin, PTH, 25-OH vitamin D total and calcium were analyzed. Serum NTX and PTH levels in patients with osteoporosis 
were significant higher than controls. Serum endotoxin was significantly and positively associated with calcium in 
all subject and controls. Endotoxin was positively associated with NTX in both groups but not with osteocalcin, PTH 
or 25-OH vitamin D. Findings of the present study implicate a role for endotoxin-mediated inflammation in patients 
with osteoporosis.
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Introduction
Osteoporosis is an important metabolic bone 
disease characterized by low bone mineral den-
sity (BMD) due to calcium and bone protein 
depletion [1]. The World Health Organization 
(WHO) [2] operationally defines osteoporosis as 
having a BMD score >2.5 standard deviations 
(SD) below the mean for a young, healthy adult 
woman. Osteoporosis affects 200 million peo-
ple worldwide [3]. In Saudi Arabia, the preva-
lence of osteoporosis (≥50 years) is as high as 
44.5% in Saudi women and 33.2% in Saudi 
men [4]. Moreover, the incidence of fragility 
fractures jumped from 2.9/1000 in 1999 [5] to 
6/1000 in 2007 at an annual cost of SR 4.27 
billion ($1=SR3.75) [6].
Currently, osteoporosis is viewed as a hetero-
geneous condition which can occur at any age, 
but certain populations such as postmeno-
pausal women have a higher risk due to factors 
such as changes in estrogen and low vitamin D 
[7]. Studies have reported significant associa-
tions between inflammation and osteoporosis. 
These studies have identified that osteoporosis 
is more frequent in patients with rheumatoid 
arthritis [8] and systemic lupus erythematosus 
[9]. Furthermore, the most prevalent form of 
clinically significant osteopenia and osteoporo-
sis involves chronic inflammation of bone in dis-
orders such as periodontal disease [10] and 
otitis media [11]. 
The physiological activities of lipopolysaccha-
rides (LPS) are mediated mainly by the lipid A 
component. Lipid A delivered by LPS-binding 
protein (LBP) to (CD14) on the surface of osteo-
blasts/stromal cells associates with Toll-like 
receptor-4 (TLR4) [12]. This complex can stimu-
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late receptor activator of nuclear factor kappa-
B ligand (RANKL) expression through calcium/
protein kinase C signals [13, 14]. RANKL can 
interact with its receptor RANK on osteoclast 
precursors and provide essential signals for 
osteoclast differentiation and maturation [15, 
16]. 
During bone resorption, bone degradation 
products are produced. These include N-telo- 
peptides of type I collagen (NTx) and carboxy-
terminal telopeptides of collagen type I (CTx) 
into the circulation [17]. On the other hand, dur-
ing the bone formation process, a number of 
molecules are released into the circulation 
such as bone specific alkaline phosphatase, 
procollagen 1 carboxyterminal propeptide and 
osteocalcin. These bone turnover markers 
(BTM) are not used for the diagnosis of osteo-
porosis because there is a great overlap 
between values of osteoporotic and non-osteo-
porotic patients [18]. However, prospective 
studies have demonstrated greater and faster 
reductions in BMD in those with higher bone 
turnover [19]. Low BMD in the presence of high 
BTM is more predictive of fracture then either 
risk factor alone [20]. The present study aims 
to evaluate circulating endotoxin levels and 
determine whether endotoxin correlates with 
BTM in Saudi post-menopausal women with 
and without osteoporosis.
Materials and methods
Study population
This study included a total of 200 Saudi post-
menopausal women aged ≥50 years old 
[N=100 with osteoporosis and N=100 without 
osteoporosis] recruited from the Primary Care 
Centers (PCCs), King Salman Hospital and King 
Fahd Medical City, Riyadh, kingdom of Saudi 
Arabia (KSA). All measurements were per-
formed systematically from August, 2013 to 
September, 2014. Participant’s history was 
recorded from a generalized questionnaire 
including age, age of menarche, age of meno-
pause, family history of osteoporosis, disease 
status, etc. Ethics approval was granted by the 
Ethics Committee of the College of Science, 
King Saud University, Riyadh, KSA.
Bone mineral density BMD (g/cm2) in the femo-
ral neck was measured using dual-energy X-ray 
absorptiometry DEXA (Hologic QDR 2000 Inc., 
Woltham, MA, USA) for all participants. The 
diagnostic criteria of osteoporosis was based 
on the T-score for BMD established by WHO 
(T-score value of -2.5 SD or below the mean for 
a young healthy adult woman indicate osteopo-
rosis). T-scores value between -1.0 and -2.5 SD 
indicate osteopenia and T-score value of -1.0 
SD or more as normal.
Patients with acute medical conditions that 
require immediate medical attention and with 
other associated diseases and inflammatory 
condition (illnesses fall beyond routine cold or 
flu infections) and no history of any other bone 
disease were excluded. 
Anthropometry and blood collection
Anthropometry included height (m) and weight 
(kg), determined using standardized conven-
tional methods. Waist (cm) and hip circumfer-
ences (cm) were obtained using a standardized 
non-stretchable fiber measuring tape, Waist-to-
hip ratio (WHR) was calculated as the ratio of 
waist and hip circumferences. Blood pressure 
(systolic and diastolic in mmHg) was also mea-
sured. Body mass index (BMI) was calculated 
as body weight divided by height squared (kg/
m2).
Five (5) ml fasting venous blood samples were 
collected in tubes without anticoagulant (serum 
separator tubes). Samples were then left to clot 
at room temperature for 30 minutes, and then 
centrifuged at 5000 rpm for 10 minutes. After 
that the collected sera was transferred to pre-
labeled plain tubes and stored in ice before 
being transported to\Biomarkers Research 
Program (BRP) in King Saud University, Riyadh, 
KSA, for immediate storage at -80°C until 
analysis.
Sample analysis
Serum endotoxin was analyzed using a com-
mercially available QCL-1000 LAL End Point 
Assay. Kits were purchased from Lonza, U.S. 
License No. 1775. Catalog Number: 50-647U. 
The intra- and inter-assay coefficient of varia-
tion (CV) were (3.9 60 0.46)(% and (9.6 60 
0.75)% respectively.
Serum NTx was measured using a competitive-
inhibition enzyme-linked immunosorbent assay 
(ELISA) kits purchased from Alere Scarborou- 
gh, Inc. 10 Southgate Road Scarborough, ME 
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04074 USA. Reference 9021. Intra- and inter-
assay CV were 4.6% and 6.9% respectively. 
Osteocalin and 25-OH vitamin D were deter-
mined by electrochemiluminescence immuno-
assay, kit purchased from (Roche Diagnostics, 
Mannheim, Germany). Intra- and inter-assay CV 
were 4% and 6.5% respectively. BRP is an 
accredited laboratory by the 25-OH vitamin D 
External Quality Assessment Scheme (DEQAS). 
Serum PTH was determined using Luminex 
Multiplex Assay System (Luminex Inc.). (Intra- 
and inter-assay CV were 4% and 9% respective-
ly). Serum calcium was carried out using a 
chemical analyzer (Konelab, Espoo, Finland) kit 
purchased from Thermo Fisher Scientific Oy, ref 
981367. Intra- and inter-assay CV were 0.2% 
and 0.4% respectively.
Statistical analysis 
Data was analyzed using SPSS version 16.5 
(Chicago, IL, USA). Continuous data were repre-
sented as mean ± SD. Categorical data was 
presented as frequencies and percentages (%). 
Continuous variables were checked for normal-
ity (Kolmogorov-Smirnov test). Differences 
between groups were done using Student 
T-test. For non-Gaussian variables, Mann-
Whitney U test was done to compare groups. 
Associations between variables were deter-
mined using Spearman’s correlation. Univariate 
and multivariate linear regression analysis 
were performed to identify independent factors 
affecting endotoxin. A P value <0.05 was con-
sidered statistically significant.
Results 
Differences in the clinical, anthropometric and 
biochemical characteristics of subjects are 
summarized in Table 1. The mean age of sub-
jects with and without osteoporosis was not 
statistically different from one another. There 
was a significant difference with respect to 
BMI, menopause, menarche age, waist and hip 
circumference (P<0.001), (P<0.001), (P<0.030), 
(P<0.008), (P<0.001) respectively. The BMD 
lumbar volume was significantly lower in the 
osteoporosis group than controls even after 
adjusting for age, BMI, menarche and age of 
menopause (P<0.001). There was a significant-
ly higher NTx and PTH levels in the osteoporosis 
group than controls (P<0.035), (P<0.038) 
respectively. These significant differences were 
lost after adjusting for confounders. No other 
significant differences were elicited.
The bivariate associations of endotoxin with 
anthropometric and biochemical metabolic 
markers of all subjects, controls and cases are 
Table 1. Differences in clinical, anthropometric characteristics, and biochemical parameters of con-
trols versus cases
Parameter Control Osteoporosis P-value Adjusted for Age, BMI, Menarche and Age of Menopause 
N 100 100
Age (years) 55.2 ± 8.8 56.2 ± 7.2 0.374
BMI (kg/m2) 34.4 ± 5.7 31.1 ± 5.9 <0.001
Menopause (years)# 5.6 ± 4.9 10.6 ± 7.2 <0.001
Menarche age (years) 13.1 ± 1.5 13.6 ± 1.8 <0.030
Waist circumference (cm) 103.8 ± 15.0 98.2 ± 15.9 <0.008
Hip circumference (cm) 114.9 ± 13.1 108.1 ± 14.8 <0.001
Waist-Hip ratio 0.9 ± 0.1 0.9 ± 0.1 0.321
Systolic Blood Pressure (mmHg) 123.8 ± 21.2 128.4 ± 19.6 0.110
Diastolic Blood Pressure (mmHg) 77.1 ± 14.9 76.3 ± 12.6 0.662
Parathyroid Hormone (pg/ml)# 41.9 ± 87.3 7.06 ± 106.9 <0.038
BMD lumbar volume (g/cm2) -0.2 ± 0.6 -3.1 ± 0.5 <0.001 0.000
Endotoxin (IU/ml) 1.9 ± 0.9 2.1 ± 1.1 0.329 0.206
NTX (nMBCE)# 61.0 ± 44.6 76.8 ± 56.2 <0.035 0.287
Osteocalcin (ng/ml) 11.3 ± 6.3 11.1 ± 6.9 0.885 0.193
25(OH) Vitamin D (nmol/l) 59.2 ± 30.8 63.2 ± 35.4 0.418 0.828
Calcium (mmol/l) 2.3 ± 0.2 2.3 ± 0.2 0.109 0.233
Note: Data presented as mean ± SD; significant at P<0.05.
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summarized in Table 2. Serum endotoxin 
showed a significant positive association with 
resorption observed in patients with osteo- 
porosis. 
Table 2. Bivariate associations of endotoxin with anthropometric 
and biochemical metabolic markers of all, controls and cases 
cohort
Parameter All Control Osteoporosis
N 200 100 100
Waist circumference (cm) -0.04 -0.02 -0.04
Hip circumference (cm) 0.04 0.02 0.14
Menarche Age (years) 0.07 0.08 0.001
Menopause (years)# 0.01 -0.08 0.03
First pregnancy age (years) 0.12 0.07 0.21
Systolic blood pressure (mmHg) 0.02 -0.06 -0.09
Diastolic blood pressure (mmHg) -0.03 0.03 0.000
BMI (kg/m2) -0.03 -0.15 -0.22
BMD femoral neck volume (g/cm2) 0.11 0.17 -0.16
NTX (nM BCE)# 0.09 0.15 0.02
Osteocalcin (ng/ml) -0.0001 -0.04 -0.02
25(OH) Vitamin D (nmol/l) -0.11 -0.1 -0.09
Parathyroid Hormone (pg/ml)# 0.05 -0.008 -0.08
Calcium (mmol/L) 0.24** 0.48** 0.10
Note: **denotes significance at 0.01 level.
Figure 1. A. Correlation between endotoxin and calcium concentrations in all 
subjects; B. In control group.
calcium in all subjects and 
controls (r=0.238, P<0.001; 
r=0.476, P<0.001, respec-
tively). A significant positive 
correlation was found be- 
tween endotoxin and calcium 
in all subjects (Figure 1A) and 
controls (Figure 1B). Results 
also showed positive but in- 
significant association be- 
tween NTX in all subjects. No 
significant associations were 
found between endotoxin with 
waist, hips, menopause, men-
arche, age of 1st pregnancy, 
blood pressure, BMI, BMD, 
osteocalcin, 25(OH) vitamin D 
and PTH.
Discussion 
In the present study, we de- 
termined the associations 
between endotoxin with BTMs 
in postmenopausal Saudi 
women with and without 
osteoporosis. Data obtained 
showed significantly lower 
BMI in postmenopausal wo- 
men patients with osteoporo-
sis than controls, which is in 
agreement with the previous 
observations of Reid [21]. 
Furthermore, a significant po- 
sitive association between cir-
culating endotoxin and calci-
um was elicited. LPS have 
been recently observed to 
upregulate calcium concen-
trations in animal models 
through T-type calcium chan-
nels activated by the NFκB/
ET-1 signaling pathway [22]. 
In humans, LPS also induce 
intra- and extracellular calci-
um increase in human lung 
epithelial and microvascular 
endothelial cells, highlighting 
its role in calcium mobilization 
[23]. The increase in extracel-
lular calcium is parallel to 
higher endotoxin levels and 
may represent higher bone 
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Endotoxin was previously described to partially 
cause osteoclast formation. Abu-Amer et al. 
[24] have shown that endotoxin stimulated 
osteoclast formation in vivo and in vitro. On the 
other hand, several studies demonstrated that 
LPS was a potent stimulator of various pro-
inflammatory cytokines and mediators, such as 
tumor necrosis factor (TNF)-α, interleukin (IL)-
1, and prostaglandin E2 (PGE2), produced 
chiefly by macrophages and T-lymphocytes. 
These cytokines play an important role in the 
stimulation of RANKL and maturation and dif-
ferentiation of osteoclasts and bone loss [25]. 
Surprisingly, the mechanism of endotoxin 
action is not fully understood. Sismey-Durrant 
and Hopps reported that bacterial endotoxin 
failed to activate osteoclasts using purified 
Porphyromonas gingivalis [26]. 
The relationship between BTM and osteoporo-
sis has been previously analyzed. In an obser-
vational study among osteoporosis patient, sig-
nificantly higher NTX levels were observed in 
osteoporosis [27]. Bone degradation process 
involves breakdown of type I collagen as CTx 
and NTx are used to determine the rate of bone 
resorption [18, 28]. These observations are in 
agreement with our finding since NTx was high-
er in women with osteoporosis than controls. 
These results also support a high rate of 
bone resorption in women with osteoporosis. 
Moreover as expected, the BMD values were 
significantly lower in patients with osteoporosis 
than controls. These results suggest that low 
BMD in the presence of high bone markers is 
more predictive of fracture than either risk fac-
tor alone [20]. Furthermore, though insignifi-
cant, results showed positive associations 
between endotoxin and NTX in all subjects. 
Therefore, we hypothesize that endotoxin, as a 
marker of inflammation, could be significant 
positively correlated to NTX and negatively cor-
related with osteocalcin.
A significantly higher PTH levels in the women 
with osteoporosis than controls was observed 
similar to our previous findings [27]. PTH indi-
rectly stimulates bone resorption though its 
receptors on osteoblasts. Binding PTH to its 
receptor, this occurs via activation of heterotri-
meric Gs protein to increase PKA activity and 
thereby cAMP-mediated transcriptional activity. 
IGF-1 is essential for this activity. PTH1R also 
stimulates osteoblasts to increase expression 
of RANKL via activation of cAMP/PKA pathway 
and subsequently MAPK, result in an increase 
in RANKL and CSF, and a decrease in the decoy 
receptor OPG, which enhance the recruitment 
of osteoclast precursors to form osteoclasts in 
a controlled manner, lead to stimulate osteo-
clastogenesis In the kidney, PTH suppresses 
reabsorption of phosphate, while stimulating 
tubular reabsorption of calcium [28]. 
The authors acknowledge several limitations. 
The cross-sectional study design cannot sug-
gest any causal and temporal correlations. 
Further investigations are needed to improve 
our understanding of endotoxin implication in 
inflammation in large scale to estimate associ-
ation endotoxin with BTM, also to establish on 
cytokine pattern such as TNF-α, IL-1 and PGE2 
and bone metabolism.
In conclusion, serum endotoxin was positive- 
ly associated with NTx, PTH, and calcium. 
Prospective studies are needed to determine 
whether elevated endotoxin levels constitute 
osteoporosis risk.
Acknowledgements
This project was funded by the national plan for 
science for science, Technology and Innovation 
(MAARIFAH), King Abdulaziz City for science 
and Technology, kindom of Saudi Arabia, Award 
number (11-MED-2113-02).
Disclosure of conflict of interest
None.
Address correspondence to: Nasser M Al-Daghri, 
Prince Mutaib Chair for Biomarkers of Osteoporosis, 
Biochemistry Department, College of Science, King 
Saud University, Riyadh 11451, Saudi Arabia. Tel: 
+0096614675939; Fax: +0096614675931; E-mail: 
aldaghri2011@gmail.com 
References 
[1] Rachner TD, Khosla S and Hofbauer LC. 
Osteoporosis: now and the future. Lancet 
2011; 377: 1276-1287.
[2] Kanis JA. Assessment of fracture risk and its 
application to screening for postmenopausal 
osteoporosis: synopsis of a WHO report. 
Osteoporos Int 1994; 4: 368-381.
[3] Cooper C. Epidemiology of osteoporosis. 
Osteoporos Int 1999; 9: S2-S8.
[4] Ardawi MS, Maimany AA, Bahksh TM, Nasrat 
HA, Milaat WA and Al-Raddadi RM. Bone min-
Endotoxin and bone turnover markers
10687 Int J Clin Exp Pathol 2016;9(10):10682-10687
eral density of the spine and femur in healthy 
Saudis. Osteoporos Int 2005; 16: 43-55.
[5] Al-Nuaim A, Kremli M, Al-Nuaim M and Sandkgi 
S. Incidence of proximal femur fracture in an 
urbanized community in Saudi Arabia. Calcif 
Tissue Int 1995; 56: 536-538.
[6] Bubshait D and Sadat-Ali M. Economic implica-
tions of osteoporosis-related femoral fractures 
in Saudi Arabian society. Calcif Tissue Int 
2007; 81: 455-458.
[7] Yun AJ and Lee PY. Maldaptation of the link be-
tween inflammation and bone turnover may 
be a key determinant of osteoporosis. Med 
Hypotheses 2004; 63: 532-537.
[8] Mikuls TR, Saag KG, Curtis J, Bridges SL Jr, 
Alarcon GS, Westfall AO, Lim SS, Smith EA, 
Jonas BL and Moreland LW. Prevalence of os-
teoporosis and osteopenia among African 
Americans with early rheumatoid arthritis: the 
impact of ethnic-specific normative data. J Natl 
Med Assoc 2005; 97: 1155.
[9] Bultink IE, Lems WF, Kostense PJ, Dijkmans BA 
and Voskuyl AE. Prevalence of and risk factors 
for low bone mineral density and vertebral 
fractures in patients with systemic lupus ery-
thematosus. Arthritis Rheum 2005; 52: 2044-
2050.
[10] Nair SP, Meghji S, Wilson M, Reddi K, White P 
and Henderson B. Bacterially induced bone 
destruction: mechanisms and misconcep-
tions. Infect Immun 1996; 64: 2371-2380.
[11] Lannigan F, O’Higgins P and McPhie P. The cel-
lular mechanism of ossicular erosion in chron-
ic suppurative otitis media. J Laryngol Otol 
1993; 107: 12-16.
[12] Beutler B and Rietschel ET. Innate immune 
sensing and its roots: the story of endotoxin. 
Nat Rev Immunol 2003; 3: 169-176.
[13] Triantafilou M and Triantafilou K. Lipopoly- 
saccharide recognition: CD14, TLRs and the 
LPS-activation cluster. Trends Immunol 2002; 
23: 301-304.
[14] Yamamoto M, Sato S, Hemmi H, Uematsu S, 
Hoshino K, Kaisho T, Takeuchi O, Takeda K and 
Akira S. TRAM is specifically involved in the 
Toll-like receptor 4-mediated MyD88-indepen- 
dent signaling pathway. Nat Immunol 2003; 4: 
1144-1150.
[15] Islam S, Hassan F, Tumurkhuu G, Dagvadorj J, 
Koide N, Naiki Y, Mori I, Yoshida T and Yokochi 
T. Bacterial lipopolysaccharide induces osteo-
clast formation in RAW 264.7 macrophage 
cells. Biochem Biophys Res Commun 2007; 
360: 346-351.
[16] Zhuang L, Jung JY, Wang EW, Houlihan P, 
Ramos L, Pashia M and Chole RA. 
Pseudomonas aeruginosa Lipopolysaccharide 
Induces Osteoclastogenesis Through a Toll-
Like Receptor 4 Mediated Pathway in Vitro and 
in Vivo. Laryngoscope 2007; 117: 841-847.
[17] Bonnick SL, Johnston CC, Kleerekoper M, 
Lindsay R, Miller P, Sherwood L and Siris E. 
Importance of precision in bone density mea-
surements. J Clin Densitom 2001; 4: 105-110.
[18] Seibel MJ. Biochemical markers of bone re-
modeling. Endocrinol Metab Clin North Am 
2003; 32: 83-113.
[19] Garnero P, Sornay-Rendu E, Duboeuf F and 
Delmas PD. Markers of bone turnover predict 
postmenopausal forearm bone loss over 4 
years: the OFELY study. J Bone Miner Res 
1999; 14: 1614-1621.
[20] Garnero P, Hausherr E, Chapuy MC, Marcelli C, 
Grandjean H, Muller C, Cormier C, Breart G, 
Meunier P and Delmas PD. Markers of bone 
resorption predict hip fracture in elderly wom-
en: the EPIDOS Prospective Study. J Bone 
Miner Res 1996; 11: 1531-1538.
[21] Reid IR. Relationships among body mass, its 
components, and bone. Bone 2002; 31: 547-
55.
[22] Zhang L, Wang L, Jiang J, Zheng D, Liu S and 
Liu C. Lipopolysaccharides upregulate calcium 
concentration in mouse uterine smooth mus-
cle cells through the T-type calcium channels. 
Int J Mol Med 2015; 35: 784-790.
[23] Zhang K, Wang P, Huang S, Wang X, Li T, Jin Y, 
Hehir M and Xu C. Different mechanism of 
LPS-induced calcium increase in human lung 
epithelial cell and microvascular endothelial 
cell: a cell culture study in a model for ARDS. 
Mol Biol Rep 2014; 41: 4253-4259.
[24] Abu-Amer Y, Ross FP, Edwards J and Teitelbaum 
SL. Lipopolysaccharide-stimulated osteoclas-
togenesis is mediated by tumor necrosis factor 
via its P55 receptor. J Clin Invest 1997; 100: 
1557.
[25] Dinarello CA. Biologic basis for interleukin-1 in 
disease. Blood 1996; 87: 2095-2147.
[26] Sismey-Durrant HJ and Hopps RM. The effect 
of lipopolysaccharide from the oral bacterium 
Bacteroides gingivalis on osteoclastic resorp-
tion of sperm-whale dentine slices in vitro. 
Arch Oral Biol 1987; 32: 911-913.
[27] Al-Daghri NM, Yakout S, Al-Shehri E, Al-Fawaz 
HA, Aljohani N and Al-Saleh Y. Inflammatory 
and bone turnover markers in relation to PTH 
and vitamin D status among Saudi postmeno-
pausal women with and without osteoporosis. 
Int J Clin Exp Med 2014; 7: 3528.
[28] Fu Q, Jilka RL, Manolagas SC and O’Brien CA. 
Parathyroid hormone stimulates receptor acti-
vator of NFκB ligand and inhibits osteoprote-
gerin expression via protein kinase A activation 
of cAMP-response element-binding protein. J 
Biol Chem 2002; 277: 48868-48875.
